Immundiagnostik AG

Immundiagnostik AG is a leading medium-sized biotechnology company headquartered in Bensheim, Germany, specializing in the development and manufacture of innovative in-vitro diagnostics (IVD) and reagents for medical research and clinical routine. Founded in 1986 by Dr. Franz Paul Armbruster, the company has established a global reputation for 'closing the gaps' in laboratory diagnostics by focusing on niche biomarkers and high-quality analytical methods. The company’s extensive portfolio includes a wide range of ELISA kits, PCR assays, and applications for HPLC and LC-MS/MS. Their primary therapeutic and diagnostic focus areas include gastroenterology (notably fecal calprotectin), cardiovascular and renal systems, bone metabolism, oxidative stress, and therapeutic drug monitoring (TDM). Immundiagnostik operates globally with representatives in over 70 countries and a dedicated North American subsidiary, Immundiagnostik, Inc.